Inhibitors of acetyl-CoA carboxylase for treatment of neuronal hypometabolism
WO2009005519A1
Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism
US2008009467A1
Combinations of medium chain triglycerides and therapeutic agents for the treatment and prevention of alzheimers disease and other diseases resulting from reduced neuronal metabolism
EP2500017A1
Use of ketogenic compounds for treatment of age-associated memory impairment
US2007179197A1
Compositions and methods for improving or preserving brain function
EP1915144A2
Method to reduce oxidative damage and improve mitochondrial efficiency
WO2004077938A2
Novel chemical entities and methods for their use in treatment of metabolic disorders
WO03028631A2
Drug targets for alzheimer's disease and other diseases associated with decreased neuronal metabolism
US6835750B1
Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism II
AU2001257451A8
Use of medium chain triglycerides for the treatment and prevention of alzheimer's disease and other diseases resulting from reduced neuronal metabolism
